What happened
Over a dozen stocks including HDFC Bank, HCLTech, Sun Pharma and KEC International announced board, deal and regulatory updates ahead of Tue, 15 Sept trade.
HDFC Bank, HCLTech and Sun Pharma lead stocks in focus for Tue, 15 Sept after a wave of Friday board decisions, deal wins and US regulatory updates set up fresh triggers for the opening bell.
HDFC Bank on 12 Sept sent two names to the RBI for its next MD & CEO for a three-year term as Sashidhar Jagdishan declined a third term, and elevated Jimmy Tata as Executive Director for three years.
HCLTech integrated CrowdStrike Falcon Guardian into its AI security services, KEC International won Rs 1,303 crore T&D orders across India, Saudi Arabia and the Americas, and Sun Pharma settled a US generic-pricing case for a confidential sum.
Also on watch: Focus Lighting's Rs 5-10 crore Ingka order, GPT Infra's Rs 85.53 crore rail signalling deal, Munjal Auto's Rs 14.31 crore land buy, Dr Reddy's two USFDA observations and Clean Science's Rs 4 dividend. Trade with levels, not hype.
Timeline: What Triggered Tuesday's Watchlist
Key events that put these stocks in focus for 15 Sept trade.
- 12 Sep 2026 — HDFC Bank board sends two MD & CEO names to RBI, elevates Jimmy Tata as ED.
- 14 Sep 2026 — KEC International announces Rs 1,303 crore T&D orders across India, Saudi Arabia, Americas.
- 11 Sep 2026 — Sun Pharma subsidiaries settle US generic-pricing antitrust litigation for confidential amount.
What to Watch Next
HDFC Bank awaits RBI approval on CEO names, HCLTech's CrowdStrike integration rollout and KEC's order execution will be tracked. Sun Pharma's settlement removes an overhang but financial impact stays undisclosed — watch disclosures and Q2 updates.
Other Triggers on the Radar
Focus Lighting (Ingka Centres, Rs 5-10 cr LEDs by Dec 2026), GPT Infra (Eastern Railway signalling, Rs 85.53 cr), Munjal Auto (Rs 14.31 cr land at Mascot Industrial City), Dr. Reddy's (2 USFDA observations in Mexico via Form FDA 2953), Clean Science (Rs 4 final + Rs 2 interim dividend, all AGM resolutions passed) and Tata Sons IPO push per RBI norms also feature.
Why it matters for me
News-heavy counters could see volatile opens as investors price leadership changes, fresh order books and resolution of US litigation overhang.
Money
Equity Investors · Traders
Traders in HDFC Bank, HCLTech, Sun Pharma and KEC International may see gap moves and higher volumes at Tuesday's open on news flow.
Work
Equity Investors · General Public
HDFC Bank's CEO succession going to RBI for approval signals a leadership transition that will shape strategy for the next three years.
Daily Life
General Public · Traders
Fresh order wins for KEC and GPT Infra and Sun Pharma's US settlement reduce near-term overhang and support order-book visibility.
What to remember
Watch volumes and follow-through, don't chase the first 15-minute spike.
HDFC Bank CEO names to RBI, HCLTech x CrowdStrike, Sun Pharma settles US case — stocks in focus today, 15 Sept.
Verified sources (8)
Top stocks in focus tomorrow: Investors must watch HDFC Bank, HCL Tech, Sun Pharma shares on Tue, 15 Sept | Triggers
↗HDFC Bank sends two names to RBI for next MD & CEO
↗HDFC Bank board approves matters for RBI review (Form 6-K, 12 Sep 2026)
↗HCLTech and CrowdStrike Expand Strategic Partnership to Advance AI Security Resilience
↗KEC International wins new orders worth Rs 1,303 crore across T&D, cables businesses
↗KEC International bags Rs 1,303-cr orders in India, overseas markets
↗Sun Pharma Settles In re Generic Pharma Pricing Anti-Trust Case
↗Sun Pharma subsidiaries settle US generic drug pricing antitrust case for confidential amount
↗Claims and linked sources
11 claimsHDFC Bank's board on 12 Sep 2026 approved and forwarded two candidate names in order of preference with proposed remuneration to RBI for the Managing Director and CEO role for a three-year tenure, after incumbent Sashidhar Jagdishan opted not to seek another term.
HDFC Bank board also approved Jimmy Tata (DIN 06888364) as a Whole-time Director designated as Executive Director for three years, re-appointed V. Srinivasa Rangan as Executive Director for one year from 23 Nov 2026 to 22 Nov 2027, and created an additional Whole-time Director position bringing the total to four.
HCL Technologies is integrating CrowdStrike Falcon Guardian into its AI security services as part of an expanded strategic partnership with CrowdStrike, aimed at protecting AI-powered systems, agents and data.
KEC International announced new orders worth Rs 1,303 crore across its T&D business including a 400 kV transmission line project in Northern India from a private client to evacuate power from a hydroelectric plant, 380 kV transmission line projects in Saudi Arabia, and supply of towers, hardware and poles in the Americas; T&D year-to-date order intake now stands at over Rs 7,600 crore.
Sun Pharma and its US subsidiaries Sun Pharmaceutical Industries Inc, Taro Pharmaceutical Industries Ltd and Taro Pharmaceuticals USA Inc signed a settlement agreement in the In re Generic Pharmaceuticals Pricing Antitrust Litigation before the Eastern District of Pennsylvania for a confidential amount in exchange for a full release of claims, with no admission of wrongdoing.
Focus Lighting and Fixtures secured an order worth approximately Rs 5-10 crore from Ingka Centres India for manufacture, supply and delivery of LED lights and fixtures, with delivery scheduled by December 2026.
A unit of GPT Infra secured an Rs 85.53 crore order from Eastern Railway for commissioning auto-signalling work using MSDAC for continuous track circuiting and electronic interlocking.
Munjal Auto Industries signed an agreement on 12 Sep 2026 to acquire land at Mascot Industrial City in Vitthalapur for Rs 14.31 crore to support business expansion.
USFDA completed a records assessment at Dr. Reddy's API manufacturing facility in Jiutepec Morelos Mexico from 17 Jul to 8 Sep 2026 concluding with two observations issued through Form FDA 2953.
Clean Science and Technology announced a final dividend of Rs 4 per share on top of an interim dividend of Rs 2 per share and all resolutions at its 23rd AGM were approved.
Tata Sons is reportedly facing IPO pressure as the Reserve Bank of India pushes for a public listing to ensure regulatory compliance, per a Bloomberg report cited by Mint.
Community signals
Signal-only · not reporting“Our India T&D business has secured a prestigious order from an existing private client for a transmission line project to evacuate power from a hydroelectric plant in Northern India. The International T&D business has further strengthened its presence in West Asia with multiple order wins in Saudi Arabia.”
“By integrating our AI Force and Agentic AI solutions with the Falcon platform, we are enabling an intelligence-led, autonomous security model that reduces risk and delivers total resilience across the enterprise.”